Jones Financial Companies
PBYI icon

Jones Financial Companies’s Puma Biotechnology PBYI Stock Holding History

Jones Financial Companies’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84K Buy
227
+159
+234% +$1.16K ﹤0.01% 4443
2026
Q1 		$413 Hold
68
– – ﹤0.01% 4519
2025
Q4 		$405 Hold
68
– – ﹤0.01% 4193
2025
Q3 		$329 Buy
+68
New +$288 ﹤0.01% 4085

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's PBYI Position: Q2 2026 in Review

Jones Financial Companies increased its Puma Biotechnology (PBYI) stake by 234% in Q2 2026, buying an estimated $1.16K and bringing the position to 227 shares worth $1.84K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

Jones Financial Companies first reported a position in PBYI in Q3 2025 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Jones Financial Companies held 227 shares of Puma Biotechnology worth $1.84K as of Q2 2026.
  • Jones Financial Companies bought 159 Puma Biotechnology shares in Q2 2026, an estimated $1.16K.
  • Puma Biotechnology made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4443 holding.
  • Jones Financial Companies first reported a position in Puma Biotechnology in Q3 2025 and has held it in 4 quarters since.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.